Sanofi has returned to U.S….
Sanofi has returned to U.S. artificial intelligence research biotech Earendil [...]
Sanofi has returned to U.S. artificial intelligence research biotech Earendil [...]
The gray-market drugs flooding Silicon Valley reveal a community that [...]
The FDA delivered a pair of holiday season approvals, signing [...]
After several months of running the direct-to-consumer “Soft Landing” campaign [...]
Foresee Pharmaceuticals Camcevi, currently approved as a treatment for advanced [...]
After five years, Nido Biosciences has reached the end of [...]
The emergence of next-generation KRAS G12C inhibitors has led Verastem [...]
Although it looked to be lights out for InflaRx’s C5a [...]
AbbVie and Gilead each used the holiday season to reward [...]
Johnson & Johnson and Genmab both used the festive period [...]